Thursday, January 24, 2013

• Xerox, Bristol-Myers Squibb, top expectations; Celgene misses on revenueat bizjournals.com (Thu, Jan 24)
• Everything Dies, Baby -- That's a Fact (7 Lessons From Apple)at TheStreet (Thu, Jan 24)
• Medical Stock Wrap: Celgene, Bristol, Baxter, Biogenat Investor's Business Daily (Thu, Jan 24)
• Celgene Earnings: These Results Have Investors Guessingat Wall St. Cheat Sheet (Thu, Jan 24)
• Celgene says repurchases the preferred way to return cash to shareholdersat theflyonthewall.com (Thu, Jan 24)
• Futures A Wide Mix On Earnings; Apple Crumbles, Netflix Streamsat Investor's Business Daily (Thu, Jan 24)
• 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet (Thu, Jan 24)
• CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitEDGAR Online (Thu, Jan 24)
• Celgene reports Q4 REVLIMID sales $1.002B, ABRAXANE sales $106Mat theflyonthewall.com (Thu, Jan 24)
• Celgene Reports Strong Fourth Quarter and Full Year 2012 Operating and Financial ResultsBusiness Wire (Thu, Jan 24)

Wednesday, January 23, 2013

• Threshold's Window of Success Reopensat Motley Fool (Wed, Jan 23)
• Whisper Number Impact: Earnings Preview For Celgeneat Seeking Alpha (Wed, Jan 23)
• Celgene Fourth Quarter Earnings Sneak Peekat Wall St. Cheat Sheet (Wed, Jan 23)
• Celgene’s Abraxane Benefits Pancreatic Cancer Patientsat Bloomberg (Wed, Jan 23)
• Foolish Preview: Celgene Earningsat Motley Fool (Wed, Jan 23)
• A Look At Celgene's Long Term Growthat Seeking Alpha (Wed, Jan 23)
• Seeking Balance, Not Purity, In Medicine and Drug Developmentat Forbes (Wed, Jan 23)
• Celgene's Stock Runs On A Strong Pipeline Of Drugs And Projected Salesat Seeking Alpha (Wed, Jan 23)
• Med Stocks Moving: Novartis, Map, Celgene, Abbottat Investor's Business Daily (Wed, Jan 23)
• Celgene Earnings: What To Watch Forat Seeking Alpha (Wed, Jan 23)
• Annie’s Recommended a Buy on Weakness and Stock Analyses to Trackat Wall St. Cheat Sheet (Wed, Jan 23)
• Celgene’s Abraxane Benefits Pancreatic Cancer Patientsat Bloomberg (Wed, Jan 23)
• Celgene's Pancreatic Cancer Base Hitat Motley Fool (Wed, Jan 23)
• Ahead of the Bell: Celgene cancer drug fares wellAP (Wed, Jan 23)

Tuesday, January 22, 2013

• Celgene's Abraxane Extends Life By 1.8 Months In Advanced Pancreatic Cancerat Forbes (Tue, Jan 22)

Add CELG News to My Yahoo!